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raPeX - ten years of improving safety in europe 
Follow us on twitter... @eu_consumer @eu_Health
eu rapid Information system 
(raPeX) is a ten-year old success 
story exemplifying the added 
value europe brings. It is a story 
of countries working together for 
the safety of eu consumers, a 
collective effort of the national 
authorities and eu institutions 
serving european citizens. the 10th 
anniversary of raPeX is testimony 
to the ever increasing importance 
that enforcement authorities give 
to co-operation in ensuring a safer 
single market.
raPeX is the eu rapid alert 
system between member states 
and the european commission 
on non-food products. Its role is 
to disseminate information on 
potentially dangerous products 
as soon as possible. this results 
in the earlier identification and 
earlier removal from eu markets 
of products which pose a danger 
to consumers.
the raPeX report for 2013 
was published in march. a total 
of 2 364 measures against 
dangerous non-food products 
were taken by eu member states 
and reported in raPeX in 2013. 
this figure indicates a 3.8% rise 
in alerts compared to 2012, and 
continues to confirm a trend of 
growth which has been apparent 
since the establishment of the 
toP tWeets
system in 2003. From around 200 
notifications in 2003, raPeX now 
receives and distributes more than 
2 000 notifications on a yearly 
basis.
In 2013, ”clothing, textiles and 
fashion items” and ”toys” were 
the two main product categories 
for which corrective measures 
had to be taken. among the most 
frequently notified risks caused 
by these products were chemical 
risks, risk of strangulation, risk of 
injury and choking.  
chemical risks are present both 
in clothing and toys. clothes, the 
most commonly notified category, 
pose risks of strangulation or 
injuries because of the presence of 
drawstrings and cords. Businesses 
should ensure that well-known 
risks are already taken into account 
before production and if mistakes 
happen, it is important that they 
withdraw or recall the products.
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study, ”epilobee”, were discussed on 
7 april 2014 by experts gathering in 
Brussels. the study was carried out 
using, for the first time, a harmonised 
methodology to ensure that the 
data gathered would be comparable. 
covering almost 32 000 beehives, the 
study has enabled us to obtain the 
most comprehensive picture so far on 
honeybee colony mortality across the 
participating countries. 
the survey yielded results that were 
better than expected. Winter colony 
mortality rates ranged from 3.5% to 
33.6% with a north/south geographical 
pattern. In several major beekeeping 
countries, such as Greece, Hungary or 
Italy the winter mortality was below 
10%. However, in member states with 
relatively small bee populations, such 
as Belgium or sweden, mortality in the 
bee population rose as high as 30%. 
Further collection of data will continue 
in 2014.
since 2007, there have been warnings 
from european and global publications 
about alarmingly high mortalities 
in bees in the eu and beyond. 
this prompted the commission 
and member states to step up 
their monitoring surveys and take 
actions including the ban of specific 
pesticides (i.e. neonicotinoids). the 
findings of a landmark surveillance 
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Clinical trials – vote in 
plenary on 3 April 2014
results: 594 in favour, 17 against 
and 13 abstentions 
Following the positive vote in 
Parliament, the regulation now has 
to be formally adopted by council 
and published in the official Journal. 
Its application is linked to the full 
functionality of the eu portal and 
database under development by 
the european medicines agency. It 
is expected to come into effect in 
mid-2016 at the earliest.
Council adoption of the new 
Health Programme 
on 22 march 2014, the third Health 
Programme for the union’s action 
in the field of health (2014-2020) 
entered into force. 
the call for proposals will be 
launched by sanco’s executive 
agency cHaFea, immediately after 
the publication of the annual work 
programme 2014. Publication is 
expected in april/early may 2014, 
pending the adoption of the Health 
Programme regulation in council 
and the positive opinion of the 
newly established Programme 
committee.
Medical devices – vote in 
plenary on 3 April 2014
on 2 april 2014, the european 
Parliament adopted, by large 
majority, two resolutions on the 
proposals for a regulation on 
medical devices and a regulation 
on in vitro diagnostic medical 
devices respectively. the files will 
be taken over by the next european 
Parliament.
the two proposed regulations are 
under discussion in council, and the 
Greek Presidency aims at making 
substantial progress before the 
June 2014 ePsco council meeting.
InstItutIonal neWs High-level conference discusses latest insight 
into honeybee health in europe
Bracing ourselves against Future Pandemics
most of us still remember H1n1, the 
‘swine flu’ pandemic. Back in 2009 it 
spread across the globe and affected 
over 15 000 people in the eu. the 
outbreak highlighted weaknesses in the 
mechanisms in place in eu countries 
for procuring vaccines and medicines 
needed during a health crisis. 
In the aftermath of the pandemic, 
member states asked the commission 
to introduce a common procedure 
for the joint procurement of medical 
countermeasures, and in particular 
of pandemic vaccines. this procedure 
would allow eu countries to purchase 
these medical countermeasures as 
a group, thus ensuring that they are 
available in sufficient quantities and at 
a correct price should another serious 
cross border health crisis emerge.
on 10 april, the commission adopted 
a Joint Procurement agreement for 
vaccines and other medical counter-
measures that will allow member 
states, on a voluntary basis, to join 
forces in procuring these products.
the aim is to enhance solidarity 
between participating member states 
by guaranteeing their access to 
influenza vaccines, as well as improving 
the purchasing power of those countries 
participating in the mechanism. the 
ultimate goal is that member states 
can provide their citizens with the right 
medicines at the right time to protect 
them against a pandemic.
http://ec.europa.eu/food/animals/live_animals/bees/docs/bee-report_en.pdf
http://ec.europa.eu/health/preparedness_response/joint_procurement/index_en.htm
the urgent need for an integrated 
single digital and telecoms market, 
equally benefitting all consumers and 
protecting their rights was addressed 
in  april, at the consumer summit 
2014.
the digital economy has an enormous 
potential for further development of 
the internal market. e-consumers may 
benefit from it through wider choice of 
goods and services, more competitive 
offers, more attractive prices and 
more flexible contractual terms and 
conditions. 
there are, however, some business 
practices that discriminate against the 
consumers using the digital market. 
these include simple refusal to sell 
to consumers from some member 
states, their automatic re-routing 
to national websites, and unjustified 
diversifying of sale conditions. these 
practices have spawned frustration 
and distrust on the part of consumers, 
who feel that they are being excluded 
from the internal market.
the summit produced a set of 
recommendations ranging from the 
importance of open internet, the need 
for more transparency on the use of 
consumer data, connectivity without 
borders and access to the same 
content throughout the single market. 
http://europa.eu/rapid/press-release_IP-14-411_en.htm
In BrIeF
Food chain: EP agrees on 
financial framework
Parliament endorsed, on 2 april, 
the commission’s common 
financial framework covering 
the whole food chain. this 
framework with a budget of 
almost €1.9 billion will underpin 
the animal, plant and control 
package of reforms adopted by 
the commission in may 2013. 
the reforms will simplify the 
regulatory environment and 
reduce the administrative burden 
on food business operators. 
the budget is expected to be 
available in the coming weeks.
GM cultivation – next step 
after two years of delay, 
discussions have resumed in 
council on the commission’s 
legislative proposal giving more 
freedom to member states to 
restrict or ban cultivation of 
Gmos on their territories. the 
Greek Presidency hopes to 
reach a political agreement in 
June, paving the way for second 
reading discussions between the 
european Parliament and the 
council to start in the autumn.
European Action Plan to 
reduce alcohol-related harm
the objectives of the eu alcohol 
strategy are still valid, and even 
though much has been achieved, 
alcohol related harm in europe 
remains high. to further support 
the work done under the strategy, 
sanco is working together with 
the member states through the 
committee on national alcohol 
Policy and action (cnaPa) on 
an action Plan on youth and on 
binge drinking. cnaPa will agree 
on the action Plan in their next 
meeting on the 17-18 June, 
and launch it at the High level 
cnaPa meeting on 6 october.
consumer summit 2014 - overcoming the 
hurdles to an inclusive and safe eu digital 
Human story wins eu Health Prize
Henk Blanken is a narrative journalist. 
He tells stories and likes happy endings. 
the story that won him the 1st prize in 
the eu Health Prize for Journalists on 
8 april 2014 is about carel dolman, 
a gym teacher with a young family, 
who is diagnosed with Parkinson’s 
disease at 38. carel dolman agrees 
to go through pioneering surgery, 
”deep brain stimulation”, to recover 
full control over his body. He is awake 
during most of the intervention and 
guides the neurosurgeon’s hands 
inside his brain. the story is emotional 
and gripping, but it ends well for carel.
as he stood on stage to receive his 
award, Henk Blanken told us briefly 
about his own story. Four years ago, 
at age 50, he was also diagnosed 
with Parkinson’s. He finds it more and 
more difficult to stand for long periods 
of time and knows that in 15 to 20 
years from now, he will be bound to 
a wheelchair. ”this is a life-changing 
event but it does not stop you from 
living” he says, full of determination. 
”I want to let others know about the 
disease, what it does to you and how 
you can learn to cope with it. this is 
why I am currently writing a book 
about my story.” 
We wish Henk success in his new 
venture.
We also congratulate the 2nd place 
winners christiane Hawranek and 
marco maurer (de), and the 3rd place 
winner mette dahlgard (dK).
http://www.european-consumer-summit.eu/index_en.html
ask the director General 
european Patients’ rights day focuses in 2014 on the 
empowerment of patients with chronic diseases. 
eu challenges russia in the Wto over ban on eu pig imports 
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12-14 May 
eHealth Forum in athens
18 May 
8th european Patients’ right 
day
22-25 May 
european elections
June 
rassF 35th anniversary
June 
Publication of staff Working 
doc on on-going medical 
devices enforcement (PIPs 
action plan)
June 
adoption of Gmo package for 
food and feed
Mrs. Testori, what are your views on 
patient empowerment? 
I truly believe that improving the 
lives of patients goes hand-in-hand 
with efficient healthcare systems. 
empowering patients means ensuring 
they are fully informed and in control 
of their own health care. I consider 
this approach particularly suited to 
patients with chronic diseases that 
require long-term treatment, such as 
diabetes. diabetes patients can learn 
to conduct check-ups from home and 
recognise early warning signs. relying 
on their own expertise can help them 
feel confident and secure.  
Patient empowerment and involvement 
can also be a contributing factor to the 
sustainability of healthcare systems. 
With an ageing population and a rise in 
chronic diseases, healthcare resources 
russia closed its market to eu pig imports 
at the end of January 2014. the decision 
was based on four isolated cases of 
african swine fever (asF) detected in wild 
boar at eu borders with Belarus. despite 
the eu putting in place a series of control 
measures to contain the asF virus, which 
most likely originates from russia itself, 
russia continues to apply the ban. 
Going against Wto rules, this 
disproportionate trade ban has cut 
off almost 25% of all eu pig exports, 
a massive loss for our pig producers. 
Bilateral discussions with russia have 
not been fruitful. therefore, the eu has 
are being stretched. Greater patient 
involvement could ease the pressure 
on healthcare systems and hospitals. 
But this can only work if patients and 
doctors are connected at all times. the 
commission encourages eu countries 
to make full use of technology, such as 
mHealth and eHealth, that can provide 
 Paola Testori Coggi 
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a two-fold benefit: empowering 
patients and easing the burden 
on health systems, and is 
paving the way for innovation in 
this field.
decided to resort to the Wto’s 
dispute settlement procedures by 
requesting formal consultations 
with russia.
consultations give the eu and 
russia the opportunity to find 
a satisfactory solution without 
resorting to litigation. If such a 
solution is not reached within 60 
days, the eu may request the Wto 
to set up a panel to rule on the 
legality of russia’s measures.
